Shopping Cart
Remove All
Your shopping cart is currently empty
Anticanceragent 207 (compound 10b) is an effective anticancer agent. It binds to NRAS rG4 with a KD value of 2.31 µM. It exhibits cytotoxicity and reduces NRAS protein expression, demonstrating antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Anticanceragent 207 (compound 10b) is an effective anticancer agent. It binds to NRAS rG4 with a KD value of 2.31 µM. It exhibits cytotoxicity and reduces NRAS protein expression, demonstrating antitumor activity. |
| Targets&IC50 | NRAS rG4:2.31 μM (kd) |
| In vitro | Anticancer agent 207 exhibits cytotoxicity against NRAS-mutant SK-MEL-2 melanoma cells with an IC₅₀ value of 2.0 µM over 48 hours. Additionally, this agent reduces NRAS protein expression at concentrations of 0, 0.5, and 1.0 µM over 72 hours. Furthermore, Anticancer agent 207 inhibits colony formation of SK-MEL-2 cells at 0, 0.13, and 0.25 µM over a period of 10 days. |
| In vivo | The compound Anticancer agent 207, administered at a dose of 1 mg/kg intraperitoneally on a daily basis for 21 days, is capable of reducing tumor size and weight in mice. |
| Formula | C29H39FN4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.